These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1510417)

  • 1. Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.
    Fuhr U; Anders EM; Mahr G; Sörgel F; Staib AH
    Antimicrob Agents Chemother; 1992 May; 36(5):942-8. PubMed ID: 1510417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolones.
    Fuhr U; Doehmer J; Battula N; Wölfel C; Flick I; Kudla C; Keita Y; Staib AH
    Toxicology; 1993 Oct; 82(1-3):169-89. PubMed ID: 8236273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective in-vitro inhibition of hepatic oxidative metabolism by quinolones: 7-ethoxyresorufin and caffeine as model substrates.
    Valero F; de la Torre R; Segura J
    J Pharm Pharmacol; 1991 Jan; 43(1):17-21. PubMed ID: 1676053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes.
    Fuhr U; Wolff T; Harder S; Schymanski P; Staib AH
    Drug Metab Dispos; 1990; 18(6):1005-10. PubMed ID: 1981505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of quinolones on xanthine pharmacokinetics.
    Robson RA
    Am J Med; 1992 Apr; 92(4A):22S-25S. PubMed ID: 1580270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
    Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin/ibuprofen-like anti-inflammatory agents selectively potentiate the gamma-aminobutyric acid-antagonistic effects of several norfloxacin-like quinolone antibacterial agents on [35S]t-butylbicyclophosphorothionate binding.
    Squires RF; Saederup E
    Mol Pharmacol; 1993 May; 43(5):795-800. PubMed ID: 8388990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions with quinolone antibacterials.
    Brouwers JR
    Drug Saf; 1992; 7(4):268-81. PubMed ID: 1524699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations.
    Harder S; Fuhr U; Staib AH; Wolff T
    Am J Med; 1989 Nov; 87(5A):89S-91S. PubMed ID: 2589393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
    Barnett G; Segura J; de la Torre R; Carbó M
    Eur J Clin Pharmacol; 1990; 39(1):63-9. PubMed ID: 2177401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.
    Sarkar M; Polk RE; Guzelian PS; Hunt C; Karnes HT
    Antimicrob Agents Chemother; 1990 Apr; 34(4):594-9. PubMed ID: 2344166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
    Fuhr U; Strobl G; Manaut F; Anders EM; Sörgel F; Lopez-de-Brinas E; Chu DT; Pernet AG; Mahr G; Sanz F
    Mol Pharmacol; 1993 Feb; 43(2):191-9. PubMed ID: 8429824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of drug metabolism by quinolone antibiotics.
    Edwards DJ; Bowles SK; Svensson CK; Rybak MJ
    Clin Pharmacokinet; 1988 Sep; 15(3):194-204. PubMed ID: 3052987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-quinolones inhibit biotransformation of caffeine.
    Harder S; Staib AH; Beer C; Papenburg A; Stille W; Shah PM
    Eur J Clin Pharmacol; 1988; 35(6):651-6. PubMed ID: 2853056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
    Staib AH; Harder S; Fuhr U; Wack C
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):289-3. PubMed ID: 2737798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New synthetic quinolone antibacterial agents and serum concentration of theophylline.
    Niki Y; Soejima R; Kawane H; Sumi M; Umeki S
    Chest; 1987 Oct; 92(4):663-9. PubMed ID: 3477409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine.
    Mahr G; Sörgel F; Granneman GR; Kinzig M; Muth P; Patterson K; Fuhr U; Nickel P; Stephan U
    Clin Pharmacokinet; 1992; 22 Suppl 1():90-7. PubMed ID: 1319876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.